Amended and Restated Employment Agreement with Thomas K. Equels dated July 15 2010 AMENDED EMPLOYMENT AGREEMENTEmployment Agreement • August 6th, 2010 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances)
Contract Type FiledAugust 6th, 2010 Company IndustryTHIS AMENDED EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of this 11th day of June, 2010, between HEMISPHERX BIOPHARMA, INC., a Delaware corporation (the “Company”), and Thomas K. Equels, of Miami, Florida (the “Employee” or “Equels”) and amended on July 15, 2010.
Amended and Restated Employment Agreement with Robert Dickey IV dated August 3, 2010 EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN HEMISPHERX BOIOPHARMA, INC. AND ROBERT DICKEY IVEmployment Agreement • August 6th, 2010 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledAugust 6th, 2010 Company Industry JurisdictionThis Agreement is effective as of September 1, 2010 ("Effective Date") between Hemispherx Biopharma, Inc. ("Hemispherx” or the “Company") and Robert Dickey IV ("Executive").
Amended and Restated Employment Agreement with Dr. William A. Carter dated July 15 2010 AMENDED EMPLOYMENT AGREEMENTEmployment Agreement • August 6th, 2010 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances)
Contract Type FiledAugust 6th, 2010 Company IndustryTHIS AMENDED EMPLOYMENT AGREEMENT (the “Agreement”) was made and entered into as of this 11th day of June 2010, between HEMISPHERX BIOPHARMA, INC., a Delaware corporation (the “Company”), and Dr. William Carter of Tavernier, Florida (the “Employee” or “Dr. Carter”) and amended on July 15, 2010.
Amended Advisors Agreement with The Sage Group, Inc. dated July 15 2010 AMENDED ADVISER’S AGREEMENTAdvisers Agreement • August 6th, 2010 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledAugust 6th, 2010 Company Industry JurisdictionThis Amended Advisers Agreement (the "Agreement") is entered into as of July 15, 2010 by and between HemispherX BioPharma, Inc., a Delaware Corporation ("Company"), and The Sage Group, Inc. and its employees, Principals, and Senior Directors (“Adviser”), a New Jersey corporation, with respect to the following: